Seeking Alpha

Venaxis, Inc. (APPY)

  • Martin_Kostka | Send Message 25 Nov

    Long time no hear on $APPY. Then +10% in one day and significant PM action today. Good news ahead?
      • Daniel Ward | Send Message 28 Jul

        Venaxis Remains Inexpensive After The FDA Setback $APPY
          • pat45 | Send Message 22 Apr

            $APPY to start sales in Spain soon
            Reply (3)
          • View all 3 replies
            • pat45 | Send Message 22 Apr
              : APPY euro partner laboratories Rubio is finishing studies and will launch in 17 Spanish hospitals soon. In SEC Filings from event on 4/7.
            • pat45 | Send Message 22 Apr
              : They did get CE can sell in Europe
              • Daniel Ward | Send Message 21 Apr

                Why Numerous Upside Scenarios Make Venaxis A Biotech To Buy $APPY
                Reply (4)
              • View all 4 replies
                • ceristeare | Send Message 21 Apr
                  : Appy1 + sonogram = no brainer. It should be standard practice over CT scan.
                • Daniel Ward | Send Message 21 Apr
                  : That combo certainly does seem to have a lot of potential if they can get APPY1 through the FDA
                  • Martin_Kostka | Send Message 15 Apr

                    BUY $APPY 0.50 3X
                      • pat45 | Send Message 29 Jan

                        Bot $APPY .56 it has .80 cash but .43 burn and don't know how long till test approved in USA . Has CE Mark
                        Reply (1)
                        • pat45 | Send Message 29 Jan
                          : I have been in and out of this one will hold a while now. Hope can prove equivalent soon.
                          • stem23 | Send Message 9 Dec 2014

                            $APPY - If FDA has no further inquiries, expect FDA announce no later then March. Company is confident of response to FDA questions
                              • pat45 | Send Message 4 Dec 2014

                                Bot back $APPY sales soon in Europe where it is approved and meeting with FDA soon.
                                  • Blair O'Neill | Send Message 29 Oct 2014

                                    Venaxis: Latest Clinical Data Reveals Huge Market Potential $APPY
                                      • stem23 | Send Message 27 Oct 2014

                                        $APPY STOCK MOVES on
                                          Company Description
                                          Venaxis Inc is engaged in the development and commercialization of products that address unmet diagnostic and therapeutic needs.